Linear IgA bullous dermatosis secondary to drugs: a real-world pharmacovigilance study of the FDA adverse event reporting system

BackgroundLinear IgA bullous dermatosis (LABD) is a rare autoimmune blistering disease. The induction of LABD by medications is a critical issue, with previous studies highlighting the link between specific drugs and the onset of LABD. This study aims to assess the reported associations between LABD...

Full description

Bibliographic Details

Published in:	Frontiers in Medicine
Main Authors:	Yixuan Yang, Hanzhang Xie, Shuhan Liu, Ying Jia, Bingnan Cui, Zhanshuo Xiao
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2025-01-01
Subjects:	linear IgA bullous dermatosis drug-induced linear IgA bullous dermatosis adverse event FAERS pharmacovigilance study
Online Access:	https://www.frontiersin.org/articles/10.3389/fmed.2025.1521697/full